Bill > AB1103

This bill modifies California's existing laws regarding controlled substances research by updating the role and procedures of the Research Advisory Panel. The bill allows the panel to expedite review of research projects involving Schedule I or II controlled substances that meet specific criteria, such as having independent peer review, federal research registrations, and institutional review board approvals. The chairperson can now deputize two or more panel members to review and approve research projects without a full panel vote, and these deputized members are temporarily exempt from open meeting requirements. The panel gains the ability to withdraw approval from a research project for reasonable cause, but must first provide written notice and an opportunity to address concerns. The bill extends the panel's authorization to hold closed sessions for discussing sensitive research information until January 1, 2028, and requires the panel to provide annual reports to the Legislature and Governor about approved research projects. These changes are intended to streamline the research approval process, protect confidential information, and facilitate more efficient review of controlled substances research projects while maintaining appropriate oversight and transparency.

Budget and Finance, Health and Social Services, Justice

https://leginfo.legislature.ca.gov/faces/billStatusClient.xhtml?bill_id=202520260AB1103